GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Race Oncology Ltd (ASX:RAC) » Definitions » Accounts Payable & Accrued Expense

Race Oncology (ASX:RAC) Accounts Payable & Accrued Expense : A$0.81 Mil (As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Race Oncology Accounts Payable & Accrued Expense?

Race Oncology's quarterly accounts payable & accrued expense increased from Dec. 2023 (A$0.53 Mil) to Jun. 2024 (A$1.75 Mil) but then declined from Jun. 2024 (A$1.75 Mil) to Dec. 2024 (A$0.81 Mil).

Race Oncology's annual accounts payable & accrued expense declined from Jun. 2022 (A$1.32 Mil) to Jun. 2023 (A$1.07 Mil) but then increased from Jun. 2023 (A$1.07 Mil) to Jun. 2024 (A$1.75 Mil).

Race Oncology Accounts Payable & Accrued Expense Historical Data

The historical data trend for Race Oncology's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Race Oncology Accounts Payable & Accrued Expense Chart

Race Oncology Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial Premium Member Only 0.24 0.49 1.32 1.07 1.75

Race Oncology Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.75 1.07 0.53 1.75 0.81

Race Oncology Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Race Oncology Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Race Oncology Ltd (ASX:RAC) » Definitions » Accounts Payable & Accrued Expense
Comparable Companies
ASX:OCC ASX:DXB ASX:IMU ASX:PAR ASX:AGN ASX:ATH ASX:ALA ASX:RCE ASX:EZZ ASX:ACW VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
1 Macquarie Place, Level 36, Gateway, Sydney, NSW, AUS, 2000
Website
https://www.raceoncology.com
Race Oncology Ltd is a clinical stage biopharmaceutical company with a mission to be at the heart of cancer care. Its asset, bisantrene, is a small molecule chemotherapeutic. Bisantrene has a clinical history with demonstrated therapeutic benefits in both adult and pediatric patients, a well-characterized safety profile, and compelling clinical data demonstrating an anticancer effect and less cardiotoxicity over certain anthracyclines, such as doxorubicin. It has reformulated bisantrene (RC220) to address the high unmet needs of patients across multiple oncology indications, with a clinical focus on anthracycline combinations, where Race can deliver cardioprotection and enhanced anticancer activity in solid tumors.